Background A body mass index (BMI) adjusted weight loss grading system (WLGS) is related to survival in patients with cancer. The aim of this study was to examine the applicability of the WLGS by confirming its prognostic validity, evaluating its relationship to cachexia domains, and exploring its ability to predict cachexia progression. Methods An international, prospective observational study of patients with incurable cancer was conducted. For each patient, weight loss grade was scored 0–4. Weight loss grade 0 represents a high BMI with limited weight loss, progressing through to weight loss grade 4 representing low BMI and a high degree of weight loss. Survival analyses were used to confirm prognostic validity. Analyses of varian...
Cachexia is a highly prevalent syndrome in cancer and chronic diseases. However, due to the heteroge...
Cancer cachexia is common in patients with oesophagogastric cancer (OG) and is linked to overall sur...
Background: Cachexia is common in patients with esophagogastric cancer and is associated with increa...
BackgroundA body mass index (BMI) adjusted weight loss grading system (WLGS) is related to survival ...
Acknowledgements The European Palliative Care Cancer Symptom study is a collaborative effort between...
Weight loss (WL) has long been recognized as an important factor associated with reduced quality of ...
Cancer cachexia is characterized by loss of muscle mass accompanied by a variable loss of fat mass. ...
Background: Early intervention against cachexia necessitates a predictive model. The aims of this st...
Progress in the treatment of progressive involuntary weight loss in patients with cancer (cancer cac...
BACKGROUND AND AIMS:The systemic inflammatory response is associated with the loss of lean tissue, a...
Background: Weight loss limits cancer therapy, quality of life and survival. Common diagnostic crite...
Background: Weight loss limits cancer therapy, quality of life and survival. Common diagnostic crite...
Background Cancer cachexia is a muscle-wasting syndrome that results in physical function impairment...
Cancer-associated-cachexia (CAC) is a ubiquitous characteristic of pancreatic cancer (PC) and 1/3 of...
A cancer cachexia classification into stages is warranted in order to guide treatment decisions and ...
Cachexia is a highly prevalent syndrome in cancer and chronic diseases. However, due to the heteroge...
Cancer cachexia is common in patients with oesophagogastric cancer (OG) and is linked to overall sur...
Background: Cachexia is common in patients with esophagogastric cancer and is associated with increa...
BackgroundA body mass index (BMI) adjusted weight loss grading system (WLGS) is related to survival ...
Acknowledgements The European Palliative Care Cancer Symptom study is a collaborative effort between...
Weight loss (WL) has long been recognized as an important factor associated with reduced quality of ...
Cancer cachexia is characterized by loss of muscle mass accompanied by a variable loss of fat mass. ...
Background: Early intervention against cachexia necessitates a predictive model. The aims of this st...
Progress in the treatment of progressive involuntary weight loss in patients with cancer (cancer cac...
BACKGROUND AND AIMS:The systemic inflammatory response is associated with the loss of lean tissue, a...
Background: Weight loss limits cancer therapy, quality of life and survival. Common diagnostic crite...
Background: Weight loss limits cancer therapy, quality of life and survival. Common diagnostic crite...
Background Cancer cachexia is a muscle-wasting syndrome that results in physical function impairment...
Cancer-associated-cachexia (CAC) is a ubiquitous characteristic of pancreatic cancer (PC) and 1/3 of...
A cancer cachexia classification into stages is warranted in order to guide treatment decisions and ...
Cachexia is a highly prevalent syndrome in cancer and chronic diseases. However, due to the heteroge...
Cancer cachexia is common in patients with oesophagogastric cancer (OG) and is linked to overall sur...
Background: Cachexia is common in patients with esophagogastric cancer and is associated with increa...